PT  - JOURNAL ARTICLE
AU  - Lavanya Shenbagaraj
AU  - Gillian Swift
TI  - Olmesartan-associated severe gastritis and enteropathy
AID  - 10.1136/bcr-2018-226133
DP  - 2018 Nov 01
TA  - BMJ Case Reports
PG  - e226133
VI  - 11
IP  - 1
4099  - http://casereports.bmj.com/content/11/1/e226133.short
4100  - http://casereports.bmj.com/content/11/1/e226133.full
SO  - BMJ Case Reports2018 Nov 01; 11
AB  - Olmesartan is an angiotensin II receptor antagonist, used in the treatment of hypertension. We report a case of olmesartan-associated severe gastritis with enteropathy in a 74-year-old woman who presented with mainly upper gastrointestinal symptoms. There was significant endoscopic improvement in the mucosal inflammation on stopping the drug. Subsequent gastroscopy showed mucosal healing and normal gastric and duodenal mucosa. To our knowledge, this is the first case report of olmesartan-associated gastritis and enteropathy predominantly involving and affecting the whole of stomach with limited small bowel involvement.